|1.||Bogun, Frank: 10 articles (09/2015 - 03/2008)|
|2.||Morady, Fred: 10 articles (07/2015 - 03/2008)|
|3.||Good, Eric: 10 articles (07/2015 - 03/2008)|
|4.||Crawford, Thomas: 9 articles (04/2015 - 03/2008)|
|5.||Oral, Hakan: 9 articles (04/2015 - 03/2008)|
|6.||Chugh, Aman: 9 articles (04/2015 - 03/2008)|
|7.||Pelosi, Frank: 9 articles (04/2015 - 03/2008)|
|8.||Jongnarangsin, Krit: 8 articles (04/2015 - 03/2008)|
|9.||Hasdemir, Can: 7 articles (12/2013 - 10/2008)|
|10.||Yokokawa, Miki: 6 articles (07/2015 - 07/2011)|
|1.||Ventricular Premature Complexes (Premature Ventricular Contraction)
01/01/1991 - "Compared with the control group, these patients showed a significant reduction in the number of premature ventricular contractions (PVC) at rest, as well as an increased tolerance during ergometric cycle exercise as demonstrated by an increased maximal cardiac frequency, increased maximal systolic arterial blood pressure and therefore also increased double cardiac product and reduced ST-segment depression during maximal effort. "
11/01/2007 - "RF ablation of frequent premature ventricular contractions (PVC) has recently been shown to improve left ventricular (LV) systolic function and dimensions in a few patients, however mainly when they originated from the right ventricular outflow tract. "
11/01/2015 - "Recent studies have shown that premature ventricular contractions (PVCs) could enlarge the heart, but its risk factors are incompletely understood as a single 24-hour recording cannot reflect the true PVC burden due to day-to-day variability. "
07/01/2015 - "The aim of this study was to investigate the differences on origin distribution and radiofrequency ablation characteristics between premature ventricular contractions (PVC) from left and right ventricular. "
02/01/2013 - "On the electrophysiology study, activation mapping revealed that a discrete potential preceded the premature ventricular complex (PVC) triggered polymorphic VT, which was recorded just above the pulmonary valve. "
|2.||Cardiac Arrhythmias (Arrythmia)
06/01/2012 - "We evaluated whether the administration of Mg Pidolate (MgP) in patients with PVC and PsVC is superior to placebo (P) in improving symptoms and arrhythmia frequency. "
04/01/2012 - "Improvement in LVEF after effective treatment of index ventricular arrhythmia was observed in 22 of 27 patients (TICMP group; mean PVC burden of 30.8±9.9%). "
10/01/1985 - "Two of five in the chronic PVC study showed greater than 75% arrhythmia suppression. "
04/01/2014 - "The OTVT/PVC origin was defined as the site where ablation caused arrhythmia suppression. "
11/01/2013 - "Referral to an arrhythmia specialist should be considered in patients with LV dysfunction whose PVC burden exceeds 15%. "
11/01/2012 - "Clinical experience with PVC ablation has been successful in ≥80 % of cases, and the literature reports multiple cases of marked improvement in LV function after eradicating the culprit ectopic focus in patients with PVC-mediated cardiomyopathy."
04/01/2015 - "In patients with frequent PVCs and nonischemic cardiomyopathy, EF and functional class can be improved but not always normalized by successful PVC ablation. "
08/01/2011 - "After 12 weeks, only the PVC group had cardiomyopathy, with a significant reduction in left ventricular ejection fraction (PVC, 39.7 ± 5.4% versus control, 60.7 ± 3.8%; P < 0.0001) and an increase in left ventricular end-systolic dimension (PVC, 33.3 ± 3.5 mm versus control, 23.7 ± 3.6 mm; P < 0.001). "
01/01/2016 - "A recent study raises the question that perhaps even a lower PVC burden could result in PVC cardiomyopathy and adverse outcomes. "
01/01/2016 - "Recent studies have focused on identifying the predictors of PVC-induced cardiomyopathy, with the most consistent predictors being PVC burden and PVC QRS duration. "
|4.||Heart Diseases (Heart Disease)
07/01/2010 - "EA-guided RFA is safe and effective for VT/PVC, irrespective of its origin, mechanism, sustainability, hemodynamic condition, and underlying heart disease."
09/24/2013 - "This study aimed to assess the benefit after ablation of premature ventricular complexes (PVC) in patients with frequent PVC and left ventricular (LV) dysfunction, regardless of previous structural heart disease (SHD) diagnosis, PVC morphology, or estimated site of origin. "
01/01/2013 - "In this study, 12-lead Electrocardiogram (ECG) of 87 patients without structural cardiac diseases, who had experienced PVC, were obtained. "
09/01/2012 - "Most studies on PVC prognosis in 'normal hearts' did not use advanced tests to rule out structural heart disease. "
01/01/2011 - "Totally 188 PVC patients were randomly enrolled in the non-organic heart disease PVCs trial and orally took either SSYX capsules or analogues (three times per day, 4 capsules one time). "
05/01/2012 - "There was a significant reduction in PVC-associated bloodstream infection, from 2.2 cases per 10,000 patient-days during the preintervention period (5 cases) to 0.44 cases per 10,000 patient days during the 3 intervention periods (3 cases; P = .016). "
01/01/2013 - "To study the influence of brominated furanones on the formation of Staphylococcus aureus (SA) biofilm on PVC thus providing new avenues of research on the surface modification of materials and clinical treatment of biomaterial-centered infection. "
01/01/2009 - "However, some studies report absolute PVC-BSI numbers in the range of central line-associated infections. "
05/01/2004 - "During the study period, samples from 1039 C/PVC infections were evaluated, yielding 384 (37.0%) positive cultures. "
01/01/2015 - "Predominance of infections on PVC should be subject of specific prevention actions, including retro-information strategy, prospective ES, professional practices evaluation and finally training and increasing awareness of health personnel with hygiene measures. "
|1.||Diethylhexyl Phthalate (DEHP)
|5.||Sodium Chloride (Saline Solution)
|2.||Drug Therapy (Chemotherapy)